TFFP(Delisted)
TFF Pharmaceuticals·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 0
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TFFP
Tff Pharmaceuticals, Inc.
A biotech company developing and commercializing innovative inhalation products for lung diseases and conditions
1751 River Run, Suite 400, Fort Worth, Texas 76107
--
TFF Pharmaceuticals, Inc., was incorporated in Delaware on January 24, 2018. The company is an early stage biopharmaceutical company focused on developing and commercializing innovative drugs based on its patented thin film freezing (TFF) technology platform. The company's early tests confirmed that the TFF platform can significantly improve the solubility of poorly water-soluble drugs, which account for about 40% of the world's major drugs, thereby improving the pharmacokinetic effects of these drugs.
Company Financials
EPS
TFFP has released its 2024 Q2 earnings. EPS was reported at -1.22, versus the expected -1.7, beating expectations. The chart below visualizes how TFFP has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TFFP has released its 2024 Q3 earnings report, with revenue of 193.39K, reflecting a YoY change of -17.62%, and net profit of -3.54M, showing a YoY change of 19.60%. The Sankey diagram below clearly presents TFFP's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
